Developer of MicroRNA profiling technology designed to detect genetic fragments in the blood or tissue. The company's platform leverages a proprietary digital microfluidics technology to automate manually intensive experimental workflows on a low-cost cartridge, enabling medical practitioners to have access to accurate, affordable, and minimally invasive molecular testing.
Kapplex is a Toronto-based startup developing sensitive, high-performance and multiplexed point-of-care diagnostic platforms suitable for use in doctor’s offices, urgent care, and emergency rooms to enable clinicians to rapidly and accurately diagnose a disease at a patient’s first visit and significantly improve the course of treatment while reducing healthcare costs. The Kapplex instruments and consumables are driven by a proprietary Digital Microfluidic (DMF) platform developed in Dr. Aaron Wheeler’s lab at the University of Toronto. DMF dramatically simplifies and automates traditional sample preparations and analyses on a single, low-cost chip driven by a low-cost instrument.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.